about
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbot...
Read More
0.68
0.00
(0.00%)
62,692
XNAS Volume
XNAS 18 Sep, 2025 10:14 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
BioAtla Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..